Cancer lessons from mice to humans

David Tuveson () and Douglas Hanahan ()
Additional contact information
David Tuveson: David Tuveson is at the Cancer Research UK/Cambridge Research Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Douglas Hanahan: Douglas Hanahan is at the Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology Lausanne, CH-1015 Lausanne, Switzerland.

Nature, 2011, vol. 471, issue 7338, 316-317

Abstract: New clinical trials report the efficacy of two mechanism-based therapies for treating human pancreatic neuroendocrine tumours. Studies in mouse models have contributed to these success stories, and continue to do so.

Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/471316a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:471:y:2011:i:7338:d:10.1038_471316a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/471316a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().